Table 3.
Summary of model results.
| Generalised screening approach | Current risk-based screening approach | |
|---|---|---|
| Number of patients initiating treatment | 5,108 | 4,191 |
| Total costs | US$333,593,535 | US$289,565,399 |
| Total QALYs | 1,213,151 | 1,208,359 |
| Cost per person | US$5,525 | US$4,796 |
| QALYs per person |
3.07 |
2.99 |
| Incremental cost of generalised screening approach | US$44,028,136 | |
| Incremental QALYs gained from generalised screening approach | 4,792 | |
| Incremental cost of generalised screening approach per person | US$729 | |
| Incremental QALYs gained from generalised screening approach per person | 0.08 | |
| ICER | US$9,188 per QALY | |
ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life-year.